Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.
about
Structure of a backtracked state reveals conformational changes similar to the state following nucleotide incorporation in human norovirus polymeraseInvestigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development.Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.Norovirus RNA-dependent RNA polymerase: A computational study of metal-binding preferences.ABT-450/ ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus.Beclabuvir for the treatment of hepatitis C.Asunaprevir for hepatitis C: a safety evaluation.Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C.Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients.(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.NS5B polymerase inhibitors in phase II clinical trials for HCV infection.Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications.Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
P2860
Q27696313-121C724D-D96C-4CD9-B4DF-C734BDA89409Q31051529-57D003D5-F0C2-4A90-B895-05B429371922Q34424151-48B4D503-A316-4DA4-98C1-86DAFDA44513Q38233860-DA122EC5-6B06-4EE1-8F5A-48510F04BB06Q38288438-4FD18D03-1724-4B54-90C3-3D0FB93538BAQ38387667-92DD6BA2-57C3-4E8F-B4AF-8C2441DE27F7Q38544196-A9A9D9E2-A023-4B59-A82B-0DBFDE503D75Q38578458-91C75215-E4E2-4695-B3B1-BC74640971C5Q38916167-6CCA37F1-1AD0-4B3C-B1B8-E3A8C7C9517DQ40326326-6E1FB2F2-B775-4BB3-AE1D-B5F8D4082A6CQ40929061-4E3572C3-CC42-46D6-99AF-C22821ED20AAQ41608489-81033C34-E324-4263-A5C5-A679A158C334Q47260158-8C836422-8F3C-44B0-88DC-BE63287F5EBDQ47566445-5F0D0D84-A9E3-46D1-991E-E80034F0CEB2Q47611417-771FEE31-D9CE-4F01-BA46-9917F443DA77
P2860
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Investigational nucleoside and ...... in treating hepatitis C virus.
@ast
Investigational nucleoside and ...... in treating hepatitis C virus.
@en
Investigational nucleoside and ...... in treating hepatitis C virus.
@nl
type
label
Investigational nucleoside and ...... in treating hepatitis C virus.
@ast
Investigational nucleoside and ...... in treating hepatitis C virus.
@en
Investigational nucleoside and ...... in treating hepatitis C virus.
@nl
prefLabel
Investigational nucleoside and ...... in treating hepatitis C virus.
@ast
Investigational nucleoside and ...... in treating hepatitis C virus.
@en
Investigational nucleoside and ...... in treating hepatitis C virus.
@nl
P2860
P50
P1476
Investigational nucleoside and ...... in treating hepatitis C virus.
@en
P2093
Antonio Riccardo Buonomo
Emanuela Zappulo
P2860
P304
P356
10.1517/13543784.2014.921680
P407
P577
2014-05-21T00:00:00Z